SEC Form 3 · accession 0001077183-18-000018
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephanie K Bywater
Officer — Chief Compliance Officer
Period of report
May 1, 2018
Accepted (ET)
May 10, 2018 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 528 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $7.72 | holding | — | — | — | May 15, 2018 | May 15, 2022 | Common Stock | 50,000 | — | D |
| Common StockF2 | $8.03 | holding | — | — | — | Feb 26, 2019 | Feb 26, 2023 | Common Stock | 24,000 | — | D |
Explanation of responses
- F1On May 15, 2017, Ms. Bywater was granted options to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
- F2On February 26, 2018, Ms. Bywater was granted options to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.